Julia Riedl

1.7k total citations · 1 hit paper
38 papers, 1.3k citations indexed

About

Julia Riedl is a scholar working on Internal Medicine, Oncology and Hematology. According to data from OpenAlex, Julia Riedl has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Internal Medicine, 21 papers in Oncology and 13 papers in Hematology. Recurrent topics in Julia Riedl's work include Venous Thromboembolism Diagnosis and Management (23 papers), Inflammatory Biomarkers in Disease Prognosis (13 papers) and Lymphatic System and Diseases (7 papers). Julia Riedl is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (23 papers), Inflammatory Biomarkers in Disease Prognosis (13 papers) and Lymphatic System and Diseases (7 papers). Julia Riedl collaborates with scholars based in Austria, United States and Russia. Julia Riedl's co-authors include Cihan Ay, Ingrid Pabinger, Florian Posch, Christoph Zielinski, Eva‐Maria Reitter, Simon Panzer, Alexandra Kaider, Christine Marosi, Oliver Königsbrügge and Gabriela Cesarman‐Maus and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Julia Riedl

34 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts

2018 230 citations Ingrid Pabinger, Nick van Es et al. The Lancet Haematology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julia Riedl Austria	17	706	427	371	300	169	38	1.3k
Akinori Oki Japan	19	226 0.3×	190 0.4×	82 0.2×	86 0.3×	42 0.2×	46	1.2k
L. Laterveer Netherlands	15	102 0.1×	316 0.7×	91 0.2×	648 2.2×	24 0.1×	19	1.3k
Prem Mahendra United Kingdom	9	98 0.1×	313 0.7×	36 0.1×	586 2.0×	122 0.7×	14	1.2k
Luca Laurenti Italy	14	103 0.1×	277 0.6×	27 0.1×	274 0.9×	69 0.4×	41	1.1k
Takeharu Kato Japan	21	96 0.1×	292 0.7×	39 0.1×	57 0.2×	101 0.6×	105	1.5k
Christine Mauz‐Körholz Germany	19	48 0.1×	369 0.9×	63 0.2×	163 0.5×	26 0.2×	87	1.5k
Katsuhiro Takano Japan	17	62 0.1×	176 0.4×	106 0.3×	321 1.1×	11 0.1×	28	1.1k
P. Meusers Germany	18	67 0.1×	689 1.6×	50 0.1×	519 1.7×	24 0.1×	43	1.5k
Barbara Sarina Italy	23	52 0.1×	700 1.6×	44 0.1×	885 3.0×	41 0.2×	76	1.7k
Hans Vos Netherlands	12	146 0.2×	228 0.5×	60 0.2×	217 0.7×	4 0.0×	17	971

Countries citing papers authored by Julia Riedl

Since Specialization

Citations

This map shows the geographic impact of Julia Riedl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Riedl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Riedl more than expected).

Fields of papers citing papers by Julia Riedl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Riedl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Riedl. The network helps show where Julia Riedl may publish in the future.

Co-authorship network of co-authors of Julia Riedl

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Riedl. A scholar is included among the top collaborators of Julia Riedl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Riedl. Julia Riedl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jeryczynski, Georg, et al.. (2025). Optimizing Belantamab Mafodotin in Relapsed or Refractory Multiple Myeloma: Impact of Dose Modifications on Adverse Events and Hematologic Response in a Real-World Retrospective Study. Cancers. 17(14). 2398–2398.

Riedl, Julia, et al.. (2024). Management of paroxysmal nocturnal hemoglobinuria with low-level hemolysis in pregnancy– a report of two cases. Annals of Hematology. 104(2). 1249–1253.

Schön, Julika, et al.. (2024). Lipedema: Complications in High-Volume Liposuction Are Linked to Preoperative Anemia. Journal of Clinical Medicine. 13(24). 7779–7779.

Agis, Hermine, Cihan Ay, Heinz Gisslinger, et al.. (2024). Thromboembolism and bleeding in newly diagnosed Multiple Myeloma – Rates, risk profile and patterns of thromboprophylaxis. Hämostaseologie. 1 indexed citations

Erhart, Friedrich, Georg Widhalm, Barbara Kiesel, et al.. (2024). The plasma miRNome and venous thromboembolism in high‐grade glioma: miRNA Sequencing of a nested case–control cohort. Journal of Cellular and Molecular Medicine. 28(8). e18149–e18149. 2 indexed citations

Riedl, Julia, Cihan Ay, Silvia Koder, et al.. (2019). The role of ADAMTS‐13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study. Research and Practice in Thrombosis and Haemostasis. 3(3). 503–514. 41 indexed citations

Riedl, Julia, Matthias Preusser, Florian Posch, et al.. (2018). Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism. Journal of Thrombosis and Haemostasis. 16(6). 1121–1127. 49 indexed citations

Riedl, Julia, et al.. (2018). The role of podoplanin in cancer-associated thrombosis. Thrombosis Research. 164. S34–S39. 39 indexed citations

Pabinger, Ingrid, Nick van Es, Georg Heinze, et al.. (2018). A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts. The Lancet Haematology. 5(7). e289–e298. 230 indexed citations breakdown →

10.

Riedl, Julia, Cihan Ay, & Ingrid Pabinger. (2017). Platelets and hemophilia: A review of the literature. Thrombosis Research. 155. 131–139. 12 indexed citations

11.

Riedl, Julia, Alexandra Kaider, Christine Marosi, et al.. (2016). PO-63 - Exhausted platelets in cancer patients with high risk of venous thromboembolism and poor prognosis. Thrombosis Research. 140. S199–S200. 10 indexed citations

12.

Posch, Florian, Julia Riedl, Eva‐Maria Reitter, et al.. (2016). Hypercoagulabilty, venous thromboembolism, and death in patients with cancer. Thrombosis and Haemostasis. 115(4). 817–826. 56 indexed citations

13.

Riedl, Julia, Benjamin Mordmüller, Silvia Koder, et al.. (2016). Alterations of blood coagulation in controlled human malaria infection. Malaria Journal. 15(1). 15–15. 35 indexed citations

14.

Königsbrügge, Oliver, Julia Riedl, Ella Grilz, et al.. (2016). PO-01 - Congestive heart failure is an independent risk factor for venous thromboembolism and mortality in cancer patients. Thrombosis Research. 140. S176–S176. 3 indexed citations

15.

Königsbrügge, Oliver, Silvia Koder, Julia Riedl, et al.. (2016). A new measure for in vivo thrombin activity in comparison with in vitro thrombin generation potential in patients with hyper- and hypocoagulability. Clinical and Experimental Medicine. 17(2). 251–256. 14 indexed citations

16.

Riedl, Julia, Alexandra Kaider, Christine Marosi, et al.. (2016). Decreased platelet reactivity in patients with cancer is associated with high risk of venous thromboembolism and poor prognosis. Thrombosis and Haemostasis. 117(1). 90–98. 37 indexed citations

17.

Riedl, Julia, Lena Hell, Alexandra Kaider, et al.. (2015). Association of platelet activation markers with cancer-associated venous thromboembolism. Platelets. 27(1). 80–85. 40 indexed citations

18.

Riedl, Julia, Ingrid Pabinger, & Cihan Ay. (2013). Platelets in cancer and thrombosis. Hämostaseologie. 34(1). 54–62. 79 indexed citations

19.

Riedl, Julia, Alexandra Kaider, Eva‐Maria Reitter, et al.. (2013). Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Thrombosis and Haemostasis. 111(4). 670–678. 79 indexed citations

20.

Fuehrer, Hans‐Peter, et al.. (2012). Ectoparasites of livestock, dogs, and wild rodents in the Chittagong Hill Tracts in southeastern Bangladesh. Parasitology Research. 111(4). 1867–1870. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact